3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Advanced Solid Tumor
4
Esophageal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
2
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Simpson-Golabi-Behmel syndrome
1
Recurrence
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Metastatic Solid Tumors
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Head and Neck Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Diabetes Mellitus
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Advanced Solid Tumour
1
Advanced Solid Tumors
1
Advanced Malignancies
1
Adenocarcinoma Of Esophagus
1
Interventions
Rituximab
17
Cyclophosphamide
15
Prednisone
12
Doxorubicin
10
Lenalidomide
9
ibrutinib
7
Vincristine
7
polatuzumab vedotin
5
obinutuzumab
5
Oxaliplatin
5
Magnetic Resonance Spectroscopy
5
Gemcitabine
5
venetoclax
4
glofitamab
4
fludarabine
4
Specimen Handling
4
Biopsy
4
prednylidene
3
fludarabine phosphate
3
deltacortene
3
Whole-Body Irradiation
3
R-CHOP protocol
3
Etoposide
3
Cyclosporine
3
Bendamustine Hydrochloride
3
zanubrutinib
2
pembrolizumab
2
acalabrutinib
2
Prednisolone
2
Mycophenolic Acid
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Large B-Cell, Diffuse
×
tislelizumab
×
30 days
×
Clear all
No trials found.